Intradermal HBV vaccination is preferable in non-responders
Author:
- 1 November 2009
- journal article
- editorial
- Published by Springer Nature in Nature Reviews Nephrology
- Vol. 5 (11) , 616-617
Abstract
In patients on hemodialysis with a history of failure to respond to hepatitis B vaccination, intradermal revaccination is more effective than repeat intramuscular vaccination. Intradermal vaccine administration might become the standard of care for high-risk patients.Keywords
This publication has 8 references indexed in Scilit:
- Intradermal Versus Intramuscular Hepatitis B Vaccination in Hemodialysis Patients: A Prospective Open-Label Randomized Controlled Trial in Nonresponders to Primary VaccinationAmerican Journal of Kidney Diseases, 2009
- Meta‐analysis: intradermal vs. intramuscular vaccination against hepatitis B virus in patients with chronic kidney diseaseAlimentary Pharmacology & Therapeutics, 2006
- Primary high-dose intradermal hepatitis B vaccination in hemodialysis: Cost-effectiveness evaluation at 2 yearsHemodialysis International, 2006
- Serum Antibody Responses after Intradermal Vaccination against InfluenzaNew England Journal of Medicine, 2004
- Levamisole Treatment Enhances Protective Antibody Response to Hepatitis B Vaccination in Hemodialysis PatientsArtificial Organs, 2002
- Reinforced intradermal hepatitis B vaccination in hemodialysis patients is superior in antibody response to intramuscular or subcutaneous vaccinationAmerican Journal of Kidney Diseases, 1998
- Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigenKidney International, 1998
- Influence of uraemia and haemodialysis on host defence and infectionNephrology Dialysis Transplantation, 1996